Biomarin Pharmaceutical - Registered Shares Current Cash

As of the most recent data (June 2026), BMRN shows a current cash of $870M. That compares with $1.2B in the prior-year period — down 28.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMRN's current cash is now $870M (was $1.2B) — a 28.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biomarin Pharmaceutical - Registered Shares is outperforming or lagging.

Tracking BMRN's current cash over time shows whether Biomarin Pharmaceutical - Registered Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $870M That compares with $1.2B in the prior-year period — down 28.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Biomarin Pharmaceutical - Registered Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $870M) with ownership activity and broader fundamentals.

Biomarin Pharmaceutical - Registered Shares's current cash is $870M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.